DRUG DEVELOPMENT DECONSTRUCTOR MANIFESTO: : “Tell me how you read and I'll tell you who you are.” ― Martin Heidegger
Friday, November 27, 2015
Tuesday, November 24, 2015
Who cares?
Pfizer is the largest drug maker in the United States, but after striking a deal on Monday to buy Allergan, the company is on the verge of becoming Irish.For shareholders, this may be their lucky charm. After the merger, Pfizer will be able to shift its legal headquarters from New York to Dublin and pay lower taxes, which should bolster its bottom line. But in the process, scientists are likely to lose their jobs, innovation may suffer, and consumers could pay more for Pfizer medicines.
This is often true of many large takeovers in the pharmaceutical industry as companies look to slash expenses and quickly appease investors. In this case, about $2 billion in cuts are planned. But the type of deal Pfizer is pursuing, which is known as a tax inversion, appears destined to accentuate the downsides
http://www.statnews.com/pharmalot/2015/11/23/pharmalot-pfizer-allergan-innovation/
Sunday, November 22, 2015
Sunday, November 15, 2015
Tuesday, November 10, 2015
Monday, November 9, 2015
Wednesday, November 4, 2015
Sunday, November 1, 2015
The top 10 biopharma pipeline disasters of 2015...
Targeted failures - most Epic ones...
http://www.fiercebiotech.com/special-reports/top-10-biopharma-pipeline-disasters-2015
http://www.fiercebiotech.com/special-reports/top-10-biopharma-pipeline-disasters-2015
The story...
When FDA inspectors showed up at a Chinese company that supplies key ingredients to two of the U.S.’s biggest drug companies, a curious thing happened.
After lunch, they walked into a quality control lab on the second floor, where they saw a worker pull what looked like a memory stick from a computer and put it in the pocket of his lab coat. The inspectors asked to see what he’d taken.
And then the man turned and ran.
http://www.bloomberg.com/news/articles/2015-10-28/fda-shows-up-a-man-runs-and-questions-emerge-on-china-s-drugs
